Loading clinical trials...
Loading clinical trials...
The study participant is being asked to be in a research study called LEGACY, because you were treated for high-risk neuroblastoma (HR-NBL). Primary Objective To determine the feasibility of conduct...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
St. Jude Children's Research Hospital
NCT06057948 · Neuroblastoma, High-risk Neuroblastoma, and more
NCT05272371 · High-Risk Neuroblastoma
NCT05373901 · High-risk Neuroblastoma
NCT06335745 · Neuroblastoma, High-risk Neuroblastoma, and more
NCT04501757 · High-Risk Neuroblastoma
St. Jude Children's Research Hospital
Memphis, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions